SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-13-000533
Filing Date
2013-03-18
Accepted
2013-03-18 17:27:15
Documents
11
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 lightlake10q013113.htm 10-Q 928936
2 ex31-1.htm EX-31.1 12936
3 ex31-2.htm EX-31.2 12556
4 ex32-1.htm EX-32.1 7170
5 ex32-2.htm EX-32.2 6260
  Complete submission text file 0001185185-13-000533.txt   4586580

Data Files

Seq Description Document Type Size
6 lltp-20130131.xml EX-101.INS 551387
7 lltp-20130131.xsd EX-101.SCH 49601
8 lltp-20130131_cal.xml EX-101.CAL 25674
9 lltp-20130131_def.xml EX-101.DEF 212600
10 lltp-20130131_lab.xml EX-101.LAB 321143
11 lltp-20130131_pre.xml EX-101.PRE 217206
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 13699073
SIC: 1000 Metal Mining